Showing results (11-20 of 166) with videos related to
Sort By:
Pageof 17
International Journal of Clinical Pharmacology, Therapy, and Toxicology|August 1, 1992
Sample size determination: extended tables for the multiplicative model and bioequivalence ranges of 0.9 to 1.11 and 0.7 to 1.43E Diletti, D Hauschke, V W SteinijansPulmonary Pharmacology|October 1, 1994
Effects of lung surfactant factor (LSF) treatment on gas exchange and histopathological changes in an animal model of adult respiratory distress syndrome (ARDS): comparison of recombinant LSF with bovine LSFD Häfner, P G Germann, D HauschkeAmerican Journal of Respiratory and Critical Care Medicine|July 9, 1998
Effects of rSP-C surfactant on oxygenation and histology in a rat-lung-lavage model of acute lung injuryD Häfner, P G Germann, D HauschkeInternational Journal of Clinical Pharmacology, Therapy, and Toxicology|February 1, 1990
A distribution-free procedure for the statistical analysis of bioequivalence studiesD Hauschke, V W Steinijans, E DilettiInternational Journal of Clinical Pharmacology and Therapeutics|July 1, 1995
A confirmatory strategy for therapeutic equivalence trialsM KieserBundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|May 12, 2005
[Biometrical methods for the proof of efficacy in regulatory submissions. Non-inferiority in clinical studies]J Röhmel, D Hauschke, A Koch, et al.Pathology, Research and Practice|June 1, 1992
Comparison of the ECL-cell frequency in the stomachs of 3 different rat strainsK Tuch, D Ockert, D Hauschke, et al.British Journal of Pharmacology|August 28, 1998
Comparison of rSP-C surfactant with natural and synthetic surfactants after late treatment in a rat model of the acute respiratory distress syndromeD Häfner, P G Germann, D HauschkeInternational Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1992
Sample size determination: extended tables for the multiplicative model and bioequivalence ranges of 0.9 to 1.11 and 0.7 to 1.43E Diletti, D Hauschke, V W SteinijansCurrent Opinion in Cardiology|August 15, 2017
Graft quality verification in coronary artery bypass graft surgery: how, when and why?Teresa M KieserPageof 17